Mobile Trading

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01031Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE1319.35-21.5 (-1.6 %)
PREV CLOSE ( ) 1340.85
OPEN PRICE ( ) 1327.95
BID PRICE (QTY) 1318.30 (37)
OFFER PRICE (QTY) 1319.00 (11)
VOLUME 38379
TODAY'S LOW / HIGH ( )1315.00 1332.60
52 WK LOW / HIGH ( )1025.9 1420.2
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)334.41270.55131.16117.28121.90
   CEPS(Rs)84.5169.1240.2438.2338.38
   DPS(Rs)40.0040.0030.0025.0025.00
   Book NAV/Share(Rs)1686.061388.981145.981052.59932.31
   Tax Rate(%)22.5425.4828.7132.32-7.44
Margin Ratios
   Core EBITDA Margin(%)28.3225.7417.4920.3214.10
   EBIT Margin(%)26.3225.1014.6515.6511.33
   Pre Tax Margin(%)25.7124.5214.2115.1410.76
   PAT Margin (%)19.9118.2710.1310.2511.57
   Cash Profit Margin (%)25.1623.3415.5416.7018.21
Performance Ratios
   ROA(%)16.0815.018.088.219.20
   ROE(%)21.7621.3611.9311.8213.76
   ROCE(%)26.8626.2214.5915.4911.12
   Asset Turnover(x)0.810.820.800.800.80
   Sales/Fixed Asset(x)1.041.010.960.920.94
   Working Capital/Sales(x)1.842.102.692.963.25
Efficiency Ratios
   Fixed Capital/Sales(x)0.960.991.041.081.07
   Receivable days99.54103.0198.6095.7493.92
   Inventory Days73.1273.6581.5777.1171.52
   Payable days108.56108.0799.98100.1495.02
Valuation Parameters
   PER(x)18.4117.0832.8338.5025.57
   PCE(x)14.5713.3721.4023.6316.24
   Price/Book(x)3.653.333.764.293.34
   Yield(%)0.650.870.700.550.80
   EV/Net Sales(x)3.683.113.373.993.07
   EV/Core EBITDA(x)11.6610.3517.0818.2917.41
   EV/EBIT(x)13.9612.3723.0025.5327.12
   EV/CE(x)3.403.113.213.683.02
   M Cap / Sales3.673.123.333.942.96
Growth Ratio
   Net Sales Growth(%)13.5414.5013.118.7413.39
   Core EBITDA Growth(%)19.2274.142.1834.63-12.08
   EBIT Growth(%)19.0796.105.9350.23-18.18
   PAT Growth(%)23.75106.5211.83-3.673.90
   EPS Growth(%)23.60106.2711.83-3.793.77
Financial Stability Ratios
   Total Debt/Equity(x)0.070.060.180.170.14
   Current Ratio(x)2.592.371.821.791.75
   Quick Ratio(x)1.921.801.301.231.26
   Interest Cover(x)43.0943.3632.9630.7320.18
   Total Debt/Mcap(x)0.020.020.050.040.04

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.